KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 293 filers reported holding KARUNA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $24,641,886 | +567.4% | 77,855 | +256.5% | 11.57% | +430.1% |
| Q3 2023 | $3,692,418 | -22.0% | 21,837 | 0.0% | 2.18% | -26.5% |
| Q2 2023 | $4,735,353 | +19.4% | 21,837 | 0.0% | 2.97% | +8.3% |
| Q1 2023 | $3,966,473 | -7.6% | 21,837 | 0.0% | 2.74% | -21.4% |
| Q4 2022 | $4,290,971 | +31.8% | 21,837 | +50.8% | 3.49% | +41.8% |
| Q3 2022 | $3,256,000 | +3.0% | 14,476 | -42.0% | 2.46% | +9.9% |
| Q2 2022 | $3,160,000 | -0.2% | 24,976 | 0.0% | 2.24% | +41.2% |
| Q1 2022 | $3,167,000 | -3.2% | 24,976 | 0.0% | 1.58% | +12.4% |
| Q4 2021 | $3,272,000 | +48.5% | 24,976 | +38.7% | 1.41% | +49.3% |
| Q3 2021 | $2,203,000 | +48.6% | 18,006 | +38.4% | 0.94% | +15.0% |
| Q2 2021 | $1,483,000 | -5.2% | 13,006 | 0.0% | 0.82% | -25.3% |
| Q1 2021 | $1,564,000 | +18.4% | 13,006 | 0.0% | 1.10% | -5.1% |
| Q4 2020 | $1,321,000 | +241.3% | 13,006 | +159.8% | 1.16% | +208.0% |
| Q3 2020 | $387,000 | – | 5,006 | – | 0.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 1,952,441 | $150,963,000 | 11.19% |
| Eventide Asset Management | 901,077 | $69,671,000 | 1.36% |
| First Light Asset Management, LLC | 128,200 | $9,912,000 | 1.02% |
| Prosight Management, LP | 15,826 | $1,224,000 | 0.58% |
| MOODY ALDRICH PARTNERS LLC | 30,970 | $2,395,000 | 0.50% |
| PFM Health Sciences, LP | 137,960 | $10,667,000 | 0.49% |
| Rock Springs Capital Management LP | 244,106 | $18,874,000 | 0.48% |
| Atika Capital Management LLC | 73,500 | $5,683,000 | 0.46% |
| Hood River Capital Management LLC | 132,400 | $10,237,000 | 0.44% |
| CATALYST PRIVATE WEALTH, LLC | 5,006 | $387,000 | 0.38% |